A randomized phase II study of docetaxel alone or in combination with PANVAC-V (vaccinia) and PANVAC-F (fowlpox) in patients with metastatic breast cancer (NCI 05-C-0229).

Philip M Arlen, Mary Pazdur, Lisa Skarupa, Myrna Rauckhorst, James L Gulley

Journal: Clinical breast cancer 2006;7(2):176-9

PMID: 16800982

Full Text on Elsevier Science View on PubMed

Abstract

Address: Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute/National Institutes of Health, Bethesda, MD 20892-1750, USA. [email protected]

DOI: 10.3816/CBC.2006.n.032

Link outs

Free resources

Medical:

Other Literature Sources:

https://www.lens.org/lens/search/patent/list?q=ref...

Subscription / membership required

Full Text Sources:

MeSH Terms: Antineoplastic Agents, Phytogenic, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Cancer Vaccines, Clinical Trials, Phase II as Topic, Docetaxel, Female, Humans, Neoplasm Metastasis, Poxviridae, Randomized Controlled Trials as Topic, Research Design, Taxoids